We are live on ! Find out more
FV2GP

Flagship Ventures 2007 General Partner Portfolio holdings

AUM $107M
This Fund
S&P 500
This Quarter Est. Return
+12.04%
1 Year Est. Return
–
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$246M
AUM Growth
+$44.8M
Cap. Flow
+$25.5M
Cap. Flow %
10.38%
Top 10 Hldgs %
100%
Holding
5
New
1
Increased
–
Reduced
1
Closed
–

Top Buys

Rank Stock Value
1
MCRB icon
Seres Therapeutics
MCRB
+$26.1M

Top Sells

Rank Stock Value
1
REGI
Renewable Energy Group, Inc.
REGI
+$607K

Sector Composition

Rank Sector Weight
1 Healthcare 99.44%
2 Materials 0.16%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
AGIO icon
1
Agios Pharmaceuticals
AGIO
$2.36B
$215M 87.15%
1,930,369
– –
MCRB icon
2
Seres Therapeutics
MCRB
$51.6M
$24.9M 10.1%
+29,965
New +$26.1M
CARM
3
DELISTED
Carisma Therapeutics
CARM
$5.38M 2.18%
95,350
– –
BGMD
4
DELISTED
BG MEDICINE INC COM STK NEW
BGMD
$970K 0.39%
441,072
– –
REGI
5
DELISTED
Renewable Energy Group, Inc.
REGI
$404K 0.16%
34,952
-59,217
-63% -$607K

Similar funds

EIGI
Elmrox Investment Group IM New York $107M AUM
BPV
Battery Partners VII Boston, Massachusetts $108M AUM 8.59% 1-Year Est. Return
HDE
Hutner Daniel Ellsworth $117M AUM
WCM
Weyland Capital Management Portsmouth, New Hampshire $94M AUM 1.28% 1-Year Est. Return
NCM
Newgate Capital Management Greenwich, Connecticut $121M AUM 3.73% 1-Year Est. Return
WCM
Wesley Capital Management New York $86M AUM 10.39% 1-Year Est. Return
EGA
Emerging Global Advisors New York $140M AUM 5.42% 1-Year Est. Return
TAG
Tactical Allocation Group Birmingham, Michigan $62.6M AUM 2.17% 1-Year Est. Return

Flagship Ventures 2007 General Partner's Q2 2015 Portfolio in Review

As of Q2 2015, Flagship Ventures 2007 General Partner held 5 positions worth $246M, up 22% from $201M the previous quarter. Its ten largest holdings account for 100% of the portfolio.

Flagship Ventures 2007 General Partner deployed $25.5M of net new capital in Q2 2015, opening 1 new position. Its largest new stake was Seres Therapeutics: 29,965 shares worth $24.9M.

By sector, the portfolio is most concentrated in Healthcare at 99% of assets, up from 99% a quarter earlier, followed by Materials.

On the sell side, the largest reduction was Renewable Energy Group, Inc., an estimated $607K trimmed.

  • Flagship Ventures 2007 General Partner's largest Q2 2015 buy was Seres Therapeutics: 29,965 shares worth $24.9M.
  • Flagship Ventures 2007 General Partner's biggest Q2 2015 reduction was Renewable Energy Group, Inc., cutting an estimated $607K.
  • Flagship Ventures 2007 General Partner's ten largest holdings make up 100% of its $246M portfolio in Q2 2015.
  • Flagship Ventures 2007 General Partner opened 1 new position and closed 0 in Q2 2015.
  • Flagship Ventures 2007 General Partner's portfolio value rose 22% quarter-over-quarter to $246M.

Based on Flagship Ventures 2007 General Partner's 13F filing for Q2 2015, filed 28 Jul 2015.